Clinical Cancer Research, Vol 1, Issue 12 1455-1461, Copyright © 1995 by American Association for Cancer Research

ARTICLES

Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications

MM Tanner, M Tirkkonen, A Kallioniemi, K Holli, C Collins, D Kowbel, JW Gray, OP Kallioniemi and J Isola
Laboratory of Cancer Genetics, Tampere University Hospital and Institute of Medical Technology, P.O. Box 2000, Fin-33521 Tampere, Finland.

Amplification of the chromosome 20q13 region was recently discovered in breast cancer by comparative genomic hybridization and subsequently further defined by fluorescence in situ hybridization with specific probes. The target gene of the amplification remains unknown. Here, fluorescence in situ hybridization with a cosmid probe for the minimal region of amplification (RMC20C001) was used to study 20q13 amplification in 132 primary breast carcinomas and 11 metastases. The size of the amplicon was studied with four flanking probes. Thirty-eight (29%) primary tumors and 3 (27%) metastases showed increased copy number of the RMC20C001 probe (>1.5-fold relative to the p-arm control). Nine (6.8%) of the primary tumors were highly (>3-fold) amplified. Although the size and location of the amplified region varied from one tumor to another, only the RMC20C001 probe was consistently amplified. 20q13 amplification was significantly associated with a high histological grade (P = 0.01), DNA aneuploidy (P = 0.01), and high S-phase fraction (P = 0.0085). High-level amplification was also associated with short disease-free survival of patients with node-negative breast cancer (P = 0.002). We conclude that high-level 20q13 amplification may be an indicator of poor clinical outcome in node-negative breast cancer and that this chromosomal region is likely to contain a gene with an important role in breast cancer progression. A large definitive study is warranted to assess the independent prognostic value of 20q13 amplification.

This article has been cited by other articles:

				L. M. Davis, C. Harris, L. Tang, P. Doherty, P. Hraber, Y. Sakai, T. Bocklage, K. Doeden, B. Hall, J. Alsobrook, et al. Amplification Patterns of Three Genomic Regions Predict Distant Recurrence in Breast Carcinoma J. Mol. Diagn., July 1, 2007; 9(3): 327 - 336. [Abstract] [Full Text] [PDF]

				S. R. Krig, V. X. Jin, M. C. Bieda, H. O'Geen, P. Yaswen, R. Green, and P. J. Farnham Identification of Genes Directly Regulated by the Oncogene ZNF217 Using Chromatin Immunoprecipitation (ChIP)-Chip Assays J. Biol. Chem., March 30, 2007; 282(13): 9703 - 9712. [Abstract] [Full Text] [PDF]

				J. Akao, H. Matsuyama, Y. Yamamoto, K. Sasaki, and K. Naito Chromosome 20q13.2 Gain May Predict Intravesical Recurrence after Nephroureterectomy in Upper Urinary Tract Urothelial Tumors Clin. Cancer Res., December 1, 2006; 12(23): 7004 - 7008. [Abstract] [Full Text] [PDF]

				C. Ginestier, N. Cervera, P. Finetti, S. Esteyries, B. Esterni, J. Adelaide, L. Xerri, P. Viens, J. Jacquemier, E. Charafe-Jauffret, et al. Prognosis and Gene Expression Profiling of 20q13-Amplified Breast Cancers Clin. Cancer Res., August 1, 2006; 12(15): 4533 - 4544. [Abstract] [Full Text] [PDF]

				G. Huang, S. Krig, D. Kowbel, H. Xu, B. Hyun, S. Volik, B. Feuerstein, G. B. Mills, D. Stokoe, P. Yaswen, et al. ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction Hum. Mol. Genet., November 1, 2005; 14(21): 3219 - 3225. [Abstract] [Full Text] [PDF]

				C.-T. R. Yu, J.-M. Hsu, Y.-C. G. Lee, A.-P. Tsou, C.-K. Chou, and C.-Y. F. Huang Phosphorylation and Stabilization of HURP by Aurora-A: Implication of HURP as a Transforming Target of Aurora-A Mol. Cell. Biol., July 15, 2005; 25(14): 5789 - 5800. [Abstract] [Full Text] [PDF]

				N. A. Bergamo, L. C. da Silva Veiga, P. P. dos Reis, I. N. Nishimoto, J. Magrin, L. P. Kowalski, J. A. Squire, and S. R. Rogatto Classic and Molecular Cytogenetic Analyses Reveal Chromosomal Gains and Losses Correlated with Survival in Head and Neck Cancer Patients Clin. Cancer Res., January 15, 2005; 11(2): 621 - 631. [Abstract] [Full Text] [PDF]

				Q. Dai, Q.-Y. Cai, X.-O. Shu, A. Ewart-Toland, W.-Q. Wen, A. Balmain, Y.-T. Gao, and W. Zheng Synergistic Effects of STK15 Gene Polymorphisms and Endogenous Estrogen Exposure in the Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2065 - 2070. [Abstract] [Full Text] [PDF]

				S. Sen, H. Zhou, R.-D. Zhang, D. S. Yoon, F. Vakar-Lopez, S. Ito, F. Jiang, D. Johnston, H. B. Grossman, A. C. Ruifrok, et al. Amplification/Overexpression of a Mitotic Kinase Gene in Human Bladder Cancer J Natl Cancer Inst, September 4, 2002; 94(17): 1320 - 1329. [Abstract] [Full Text] [PDF]

				S. Biggins and A. W. Murray The budding yeast protein kinase Ipl1/Aurora allows the absence of tension to activate the spindle checkpoint Genes & Dev., December 1, 2001; 15(23): 3118 - 3129. [Abstract] [Full Text] [PDF]

				E. Vega-Saenz de Miera, D. H. P. Lau, M. Zhadina, D. Pountney, W. A. Coetzee, and B. Rudy KT3.2 and KT3.3, Two Novel Human Two-Pore K+ Channels Closely Related to TASK-1 J Neurophysiol, July 1, 2001; 86(1): 130 - 142. [Abstract] [Full Text] [PDF]

				D. G. Ginzinger, T. E. Godfrey, J. Nigro, D. H. Moore II, S. Suzuki, M. G. Pallavicini, J. W. Gray, and R. H. Jensen Measurement of DNA Copy Number at Microsatellite Loci Using Quantitative PCR Analysis Cancer Res., October 1, 2000; 60(19): 5405 - 5409. [Abstract] [Full Text]

				W.'e. El-Rifai, M. Sarlomo-Rikala, L. C. Andersson, S. Knuutila, and M. Miettinen DNA Sequence Copy Number Changes in Gastrointestinal Stromal Tumors: Tumor Progression and Prognostic Significance Cancer Res., July 1, 2000; 60(14): 3899 - 3903. [Abstract] [Full Text]

				S. Hidaka, T. Yasutake, H. Takeshita, M. Kondo, T. Tsuji, A. Nanashima, T. Sawai, H. Yamaguchi, T. Nakagoe, H. Ayabe, et al. Differences in 20q13.2 Copy Number between Colorectal Cancers with and without Liver Metastasis Clin. Cancer Res., July 1, 2000; 6(7): 2712 - 2717. [Abstract] [Full Text]

				M. Cuny, A. Kramar, F. Courjal, V. Johannsdottir, B. Iacopetta, H. Fontaine, J. Grenier, S. Culine, and C. Theillet Relating Genotype and Phenotype in Breast Cancer: An Analysis of the Prognostic Significance of Amplification at Eight Different Genes or Loci and of p53 Mutations Cancer Res., February 1, 2000; 60(4): 1077 - 1083. [Abstract] [Full Text]

				T. Tanaka, M. Kimura, K. Matsunaga, D. Fukada, H. Mori, and Y. Okano Centrosomal Kinase AIK1 Is Overexpressed in Invasive Ductal Carcinoma of the Breast Cancer Res., May 1, 1999; 59(9): 2041 - 2044. [Abstract] [Full Text] [PDF]

				C. Collins, J. M. Rommens, D. Kowbel, T. Godfrey, M. Tanner, S.-i. Hwang, D. Polikoff, G. Nonet, J. Cochran, K. Myambo, et al. Positional cloning of ZNF217 and NABC1: Genes amplified at 20q13.2 and overexpressed in breast carcinoma PNAS, July 21, 1998; 95(15): 8703 - 8708. [Abstract] [Full Text] [PDF]

				C. Collins, S. Volik, D. Kowbel, D. Ginzinger, B. Ylstra, T. Cloutier, T. Hawkins, P. Predki, C. Martin, M. Wernick, et al. Comprehensive Genome Sequence Analysis of a Breast Cancer Amplicon Genome Res., June 1, 2001; 11(6): 1034 - 1042. [Abstract] [Full Text] [PDF]